Study List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Report Bug
Study List
You are on Page 760 of 776:
750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770

Clinical Studies

NCT Number Gene Therapy Sponsor Status Brief Title Phase View
NCT00096850 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults NA View
NCT00096759 Positive Gene Therapy National Center for Complementary and Integrative Health (NCCIH) COMPLETED Comparing Tai Chi Chih and Relaxation Therapy in the Treatment of Rheumatoid Arthritis PHASE2 View
NCT00096733 Positive Gene Therapy Arbor Research Collaborative for Health COMPLETED Adult-to-Adult Living Donor Liver Transplantation Study View
NCT00096720 Institute for Neurodegenerative Disorders COMPLETED Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease PHASE2 View
NCT00096694 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Effect of an Intrauterine Contraceptive Device (IUD) in HIV Infected Women NA View
NCT00096668 Achieve Life Sciences COMPLETED Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer PHASE2 View
NCT00096603 Genentech, Inc. COMPLETED A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g PHASE3 View
NCT00096551 National Cancer Institute (NCI) COMPLETED A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy PHASE1 View
NCT00096460 Medical College of Wisconsin TERMINATED Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) PHASE2 View
NCT00096434 National Cancer Institute (NCI) COMPLETED Sorafenib in Treating Patients With Metastatic Breast Cancer PHASE2 View
NCT00096395 National Cancer Institute (NCI) COMPLETED Sorafenib Tosylate and Gemcitabine Hydrochloride in Treating Patients With Recurrent Epithelial Ovarian Cancer PHASE2 View
NCT00096369 Positive Gene Therapy University of Texas Southwestern Medical Center TERMINATED Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer PHASE2 View
NCT00096356 Wake Forest University Health Sciences COMPLETED Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer PHASE1 View
NCT00096304 Medical University of South Carolina TERMINATED Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer PHASE1 View
NCT00096200 National Cancer Institute (NCI) COMPLETED Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer PHASE2 View
NCT00096161 Positive Gene Therapy Fred Hutchinson Cancer Center COMPLETED Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant PHASE2 View
NCT00096135 Children's Oncology Group COMPLETED Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes NA View
NCT00096057 Jonsson Comprehensive Cancer Center COMPLETED Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer PHASE1 View
NCT00096018 Roswell Park Cancer Institute COMPLETED Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia PHASE1 View
NCT00096005 National Cancer Institute (NCI) TERMINATED Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas PHASE1 View
NCT00095992 NCIC Clinical Trials Group COMPLETED SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer PHASE2 View
NCT00095966 National Cancer Institute (NCI) COMPLETED Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE2 View
NCT00095758 Bristol-Myers Squibb COMPLETED A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder PHASE3 View
NCT00095732 Anthera Pharmaceuticals COMPLETED Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency PHASE2 View
NCT00095693 National Cancer Institute (NCI) TERMINATED Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer PHASE2 View
NCT00095667 National Cancer Institute (NCI) COMPLETED Lapatinib in Treating Patients With Recurrent or Metastatic Prostate Cancer PHASE2 View
NCT00095550 Positive Gene Therapy Bristol-Myers Squibb COMPLETED Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension PHASE3 View
NCT00095459 National Cancer Institute (NCI) COMPLETED BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors PHASE1 View
NCT00095433 Genentech, Inc. COMPLETED Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) PHASE3 View
NCT00095420 University of California, Los Angeles COMPLETED Relationship Training for Children With Autism and Their Peers NA View
NCT00095394 Bristol-Myers Squibb COMPLETED Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension PHASE3 View
NCT00095368 Advancis Pharmaceutical Corporation COMPLETED APC-111 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) for 10 Days in Patients With Strep Throat PHASE3 View
NCT00095303 Positive Gene Therapy University of Miami COMPLETED Brief Strategic Family Therapy for Adolescent Drug Abusers PHASE3 View
NCT00095251 Vanderbilt University COMPLETED MENDS Study: Trial in Ventilated ICU Patients Comparing an Alpha2 Agonist Versus a Gamma Aminobutyric Acid (GABA)-Agonist to Determine Delirium Rates, Efficacy of Sedation, Analgesia and Discharge Cognitive Status PHASE2 View
NCT00095160 Masonic Cancer Center, University of Minnesota COMPLETED Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors PHASE1 View
NCT00095134 Johnson & Johnson Pharmaceutical Research & Development, L.L.C. COMPLETED Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy PHASE3 View
NCT00095095 Medtronic Spinal and Biologics TERMINATED Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device PHASE4 View
NCT00095069 H. Lundbeck A/S COMPLETED Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED) PHASE3 View
NCT00095056 Merck Sharp & Dohme LLC COMPLETED An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) PHASE3 View
NCT00095004 Organon and Co COMPLETED Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) PHASE3 View
NCT00094861 Positive Gene Therapy Swedish Orphan Biovitrum COMPLETED Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE2 View
NCT00094835 Amgen COMPLETED Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) PHASE1 View
NCT00094757 Merck Sharp & Dohme LLC COMPLETED An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (MK0431-023) PHASE3 View
NCT00094718 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults PHASE1 View
NCT00094705 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults PHASE1 View
NCT00094692 Jaeb Center for Health Research COMPLETED An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old PHASE3 View
NCT00094666 H. Lundbeck A/S TERMINATED Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED) PHASE3 View
NCT00094458 Centocor Ortho Biotech Services, L.L.C. COMPLETED Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC PHASE3 View
NCT00094432 Otsuka Pharmaceutical Development & Commercialization, Inc. COMPLETED A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode PHASE3 View
NCT00094406 Positive Gene Therapy National Institutes of Health Clinical Center (CC) COMPLETED Carbon Monoxide to Prevent Lung Inflammation PHASE1 View
NCT00094393 National Human Genome Research Institute (NHGRI) COMPLETED Clinical Studies of Progeria View
NCT00094367 GlaxoSmithKline COMPLETED A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study) PHASE3 View
NCT00094302 Carelon Research COMPLETED Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function PHASE3 View
NCT00094250 National Heart, Lung, and Blood Institute (NHLBI) WITHDRAWN HEARTS: Heart, Exercise, and Resistance Training Study NA View
NCT00094159 Sunesis Pharmaceuticals COMPLETED Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors PHASE1 View
NCT00094133 Positive Gene Therapy Scott and White Hospital & Clinic UNKNOWN Hypnosis in Treating Hot Flashes in Breast Cancer Survivors NA View
NCT00094120 Genaera Corporation TERMINATED MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) PHASE2 View
NCT00094094 Pfizer COMPLETED Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer PHASE2 View
NCT00094068 National Institutes of Health Clinical Center (CC) COMPLETED The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients View
NCT00094003 NS Pharma, Inc. COMPLETED Study of NS-9 in Patients With Liver Metastases PHASE1 View
NCT00093951 Saegis Pharmaceuticals COMPLETED SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) PHASE2 View
NCT00093860 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance PHASE2 View
NCT00093834 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins COMPLETED Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer PHASE1 View
NCT00093795 NSABP Foundation Inc COMPLETED Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer PHASE3 View
NCT00093769 Jonsson Comprehensive Cancer Center COMPLETED Bortezomib and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma PHASE2 View
NCT00093756 National Cancer Institute (NCI) COMPLETED Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer PHASE1 View
NCT00093704 Jonsson Comprehensive Cancer Center TERMINATED Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma PHASE1 View
NCT00093561 University of Illinois at Chicago COMPLETED Lycopene in Preventing Prostate Cancer in Healthy Participants PHASE1 View
NCT00093457 NCIC Clinical Trials Group COMPLETED Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer PHASE2 View
NCT00093418 National Cancer Institute (NCI) COMPLETED S0432 Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia PHASE2 View
NCT00093405 Memorial Sloan Kettering Cancer Center COMPLETED 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer PHASE2 View
NCT00093366 Fred Hutchinson Cancer Center COMPLETED Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes PHASE1 View
NCT00093327 National Center for Complementary and Integrative Health (NCCIH) COMPLETED Acupuncture for Irritable Bowel Syndrome (IBS) PHASE2 View
NCT00093158 The Medicines Company COMPLETED Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS) PHASE3 View
NCT00093132 Agennix TERMINATED Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy PHASE1 View
NCT00093093 Bausch Health Americas, Inc. COMPLETED Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive PHASE3 View
NCT00093067 Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) COMPLETED Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus PHASE3 View
NCT00093002 AstraZeneca COMPLETED Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer PHASE2 View
NCT00092950 Positive Gene Therapy National Cancer Institute (NCI) COMPLETED Exercise in Women at Risk for Breast Cancer PHASE2 View
NCT00092859 Merck Sharp & Dohme LLC COMPLETED A 2-Year Study of an Investigational Drug in Obese Patients (0557-011) PHASE3 View
NCT00092833 Positive Gene Therapy Organon and Co TERMINATED Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED) PHASE3 View
NCT00092820 Organon and Co COMPLETED Sitosterolemia Extension Study (0653-004)(COMPLETED) PHASE3 View
NCT00092768 Positive Gene Therapy Organon and Co COMPLETED A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED) PHASE3 View
NCT00092703 Organon and Co COMPLETED Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED) PHASE3 View
NCT00092651 Organon and Co COMPLETED A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038) PHASE3 View
NCT00092612 Organon and Co COMPLETED Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED) PHASE3 View
NCT00092560 Organon and Co COMPLETED Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) PHASE3 View
NCT00092534 Positive Gene Therapy Merck Sharp & Dohme LLC COMPLETED Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) PHASE3 View
NCT00092495 Positive Gene Therapy Merck Sharp & Dohme LLC COMPLETED Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016) PHASE3 View
NCT00092469 Merck Sharp & Dohme LLC COMPLETED Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED) PHASE3 View
NCT00092456 Merck Sharp & Dohme LLC COMPLETED Consistency Lots Vaccine Study (V260-009) PHASE3 View
NCT00092404 Merck Sharp & Dohme LLC COMPLETED Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED) PHASE2 View
NCT00092235 National Cancer Institute (NCI) RECRUITING Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease View
NCT00092157 Organon and Co COMPLETED Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224) PHASE3 View
NCT00092118 Organon and Co COMPLETED The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) PHASE3 View
NCT00092105 Organon and Co COMPLETED Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256) PHASE3 View
NCT00092092 Organon and Co COMPLETED Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254) PHASE4 View
NCT00092066 Organon and Co COMPLETED A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) PHASE3 View
NCT00091858 Amgen COMPLETED Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer PHASE3 View
NCT00091832 Amgen COMPLETED Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer PHASE2 View
NCT00091793 Amgen COMPLETED Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis PHASE3 View
NCT00091767 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Genetic Studies in Difficult to Treat Asthma: TENOR View
NCT00091702 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents PHASE1 View
NCT00091650 Eli Lilly and Company COMPLETED Olanzapine in Patients With Borderline Personality Disorder PHASE3 View
NCT00091559 Merck Sharp & Dohme LLC COMPLETED Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) PHASE2 View
NCT00091533 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects View
NCT00091520 Scios, Inc. COMPLETED A Study of the Safety and Efficacy of Follow-up Serial Infusions of Natrecor(Nesiritide) for the Management of Patients With Heart Failure PHASE2 View
NCT00091494 University of Michigan COMPLETED Socioeconomic Patterning of Inflammation and Hemostasis - Ancillary to MESA View
NCT00091468 National Institute on Aging (NIA) UNKNOWN Nicotine Treatment of Mild Cognitive Impairment (MCI) PHASE1 View
NCT00091351 Alliance for Clinical Trials in Oncology COMPLETED Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis PHASE3 View
NCT00091260 Vaishali Sanchorawala COMPLETED CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis PHASE2 View
NCT00091234 European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia PHASE2 View
NCT00091195 National Cancer Institute (NCI) TERMINATED Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer PHASE2 View
NCT00091169 ECOG-ACRIN Cancer Research Group COMPLETED Levocarnitine in Treating Fatigue in Cancer Patients PHASE3 View
NCT00091156 European Organisation for Research and Treatment of Cancer - EORTC TERMINATED Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer PHASE3 View
NCT00091104 National Institutes of Health Clinical Center (CC) COMPLETED Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma PHASE1 View
NCT00090961 Positive Gene Therapy SWOG Cancer Research Network TERMINATED S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer NA View
NCT00090857 Dana-Farber Cancer Institute COMPLETED Letrozole in Preventing Breast Cancer in Postmenopausal Women PHASE2 View
NCT00090818 National Institute of Dental and Craniofacial Research (NIDCR) COMPLETED Clinical Research Core Dental Screening Protocol View
NCT00090766 Hoffmann-La Roche COMPLETED A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients PHASE2 View
NCT00090727 Novacea UNKNOWN Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma PHASE1 View
NCT00090558 National Heart, Lung, and Blood Institute (NHLBI) COMPLETED Effect of Nitric Oxide Donor on Endothelial Progenitor Cells in Patients With Coronary Artery Disease PHASE2 View
NCT00090532 Pfizer TERMINATED A Study Of The Safety And Efficacy Of AG-013,958 In Subjects With Subfoveal Choroidal Neovascularization Associated With Age-Related Macular Degeneration PHASE1 View
NCT00090506 National Center for Complementary and Integrative Health (NCCIH) COMPLETED Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression PHASE1 View
NCT00090493 University of Arkansas COMPLETED Study of MAGE-A3 and NY-ESO-1 Immunotherapy in Combo With DTPACE Chemo and Auto Transplantation in Multiple Myeloma PHASE2 View
NCT00090467 Brigham and Women's Hospital COMPLETED Biochemical and Genetic Markers of Hypertension in Women View
NCT00090402 Oregon Health and Science University COMPLETED Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease PHASE1 View
NCT00090259 Positive Gene Therapy Organon and Co COMPLETED Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948) PHASE3 View
NCT00090233 Positive Gene Therapy Merck Sharp & Dohme LLC COMPLETED Rotavirus Efficacy and Safety Trial (REST)(V260-006) PHASE3 View
NCT00090220 Merck Sharp & Dohme LLC COMPLETED A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) PHASE3 View
NCT00090194 National Institute of Allergy and Infectious Diseases (NIAID) TERMINATED Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10% PHASE2 View
NCT00090168 Organon and Co COMPLETED Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) PHASE3 View
NCT00090116 Forest Laboratories COMPLETED The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease PHASE3 View
NCT00090103 GlaxoSmithKline COMPLETED Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment PHASE3 View
NCT00090051 Hoffmann-La Roche COMPLETED FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients PHASE3 View
NCT00090012 Eli Lilly and Company COMPLETED Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder PHASE4 View
NCT00089960 Amgen COMPLETED Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) PHASE2 View
NCT00089895 Organon and Co COMPLETED EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED) PHASE3 View
NCT00089869 Eli Lilly and Company COMPLETED A Combination of Two Currently Approved Drugs to Enhance the Treatment of Schizophrenia PHASE1 View
NCT00089856 Cell Genesys TERMINATED GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer PHASE3 View
NCT00089804 La Jolla Pharmaceutical Company TERMINATED Study of LJP 394 in Lupus Patients With History of Renal Disease PHASE3 View
NCT00089661 Amgen COMPLETED AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer PHASE3 View
NCT00089635 Amgen COMPLETED Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer PHASE2 View
NCT00089557 NeurogesX TERMINATED An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain PHASE2 View
NCT00089518 National Institute of Allergy and Infectious Diseases (NIAID) WITHDRAWN Optimal Treatment for Kidney Disease in HIV Infected Adults PHASE3 View
NCT00089505 Positive Gene Therapy Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections COMPLETED NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission PHASE3 View
NCT00089492 Hoffmann-La Roche COMPLETED A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients PHASE2 View
NCT00089466 National Institute of Allergy and Infectious Diseases (NIAID) COMPLETED Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients PHASE1 View
NCT00089258 Memorial Sloan Kettering Cancer Center COMPLETED Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment PHASE2 View
NCT00089193 Craig L Slingluff, Jr COMPLETED Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma PHASE2 View
NCT00089167 Memorial Sloan Kettering Cancer Center COMPLETED Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis PHASE2 View
NCT00089102 Medical University of South Carolina TERMINATED Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer PHASE2 View
NCT00089050 Fred Hutchinson Cancer Center COMPLETED Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia PHASE2 View
NCT00088959 National Cancer Institute (NCI) COMPLETED Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer PHASE1 View
NCT00088933 National Cancer Institute (NCI) TERMINATED Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer PHASE1 View
NCT00088894 National Cancer Institute (NCI) COMPLETED Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE3 View
NCT00088868 National Institutes of Health Clinical Center (CC) COMPLETED 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma PHASE1 View
NCT00088803 Children's Oncology Group COMPLETED DNA Variations in the Gene in Young Patients With Wilms' Tumor View
NCT00088751 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Treatment Study of Frontotemporal Dementia View
NCT00088660 Therion Biologics Corporation UNKNOWN PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen PHASE3 View
NCT00088634 Sumitomo Pharma America, Inc. COMPLETED A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia PHASE2 View
NCT00088595 Novartis Pharmaceuticals COMPLETED Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors PHASE2 View
NCT00088569 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Effect of Direct Current Polarization on Brain Function View
NCT00088556 Telik COMPLETED Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer PHASE1 View
NCT00088504 Vertex Pharmaceuticals Incorporated COMPLETED Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C PHASE2 View
NCT00088361 National Institutes of Health Clinical Center (CC) COMPLETED Effect of Respiratory Motion on Positron Emission Tomography Imaging View
NCT00088335 National Institute of Neurological Disorders and Stroke (NINDS) COMPLETED Biological Markers in Parkinson's Disease View
NCT00088257 Harvard Pilgrim Health Care COMPLETED Maternal Fatty Acids, Child Obesity, and Asthma Immunity View
NCT00088218 M.D. Anderson Cancer Center COMPLETED Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS). PHASE2 View
NCT00088205 Positive Gene Therapy Eli Lilly and Company COMPLETED Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma PHASE2 View
NCT00088192 Eyetech Pharmaceuticals COMPLETED Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) NA View
NCT00088166 Celtic Pharma Development Services COMPLETED XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors PHASE3 View
NCT00087958 Sanofi COMPLETED Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment PHASE2 View
NCT00087932 National Center for Complementary and Integrative Health (NCCIH) COMPLETED Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment View
NCT00087893 University of Vermont COMPLETED Epidemiology of Vascular Inflammation & Atherosclerosis View
NCT00087867 Scios, Inc. COMPLETED Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma PHASE2 View
NCT00087802 Sanofi COMPLETED Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) PHASE3 View
NCT00087750 National Institute on Drug Abuse (NIDA) UNKNOWN Interaction Between Cocaine and Quetiapine - 1 PHASE1 View
NCT00087659 Positive Gene Therapy Novartis Pharmaceuticals COMPLETED A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy NA View
NCT00087633 Hoffmann-La Roche COMPLETED PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C. PHASE4 View
NCT00087620 Hoffmann-La Roche TERMINATED A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer PHASE4 View
NCT00087594 Hoffmann-La Roche COMPLETED A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. PHASE4 View
NCT00087568 Hoffmann-La Roche COMPLETED A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin PHASE4 View
NCT00087503 Pfizer COMPLETED Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy PHASE2 View
NCT00087451 Merck Sharp & Dohme LLC COMPLETED Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) PHASE1 View
NCT00087360 Fox Chase Cancer Center COMPLETED Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants NA View
NCT00087334 Roswell Park Cancer Institute TERMINATED Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer PHASE1 View
NCT00087295 Positive Gene Therapy SWOG Cancer Research Network TERMINATED S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium PHASE2 View
NCT00087269 National Cancer Institute (NCI) TERMINATED Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection PHASE2 View
NCT00087256 NSABP Foundation Inc TERMINATED Celecoxib in Preventing Polyps in Patients Who Have Undergone Surgery for Stage I Colon Cancer PHASE3 View
NCT00087204 National Cancer Institute (NCI) COMPLETED Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia PHASE1 View
NCT00087061 Jonsson Comprehensive Cancer Center COMPLETED Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma PHASE1 View
NCT00087035 Jonsson Comprehensive Cancer Center COMPLETED Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer PHASE2 View
NCT00086957 Positive Gene Therapy City of Hope Medical Center COMPLETED Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer PHASE1 View
NCT00086892 Gynecologic Oncology Group COMPLETED Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer PHASE2 View
NCT00086866 European Organisation for Research and Treatment of Cancer - EORTC UNKNOWN Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With Surgery PHASE2 View
NCT00086827 National Cancer Institute (NCI) COMPLETED Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer PHASE2 View
NCT00086658 GlaxoSmithKline COMPLETED Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) PHASE3 View
NCT00086632 Unither Pharmaceuticals TERMINATED Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment PHASE2 View
NCT00086606 Genentech, Inc. TERMINATED A Safety and Efficacy Study of Xolair in Peanut Allergy PHASE2 View